These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37303969)

  • 61. The first report of atovaquone/proguanil-induced vanishing bile duct syndrome: Case report and mini-review.
    Abugroun A; Colina Garcia I; Ahmed F; Potts S; Flicker M
    Travel Med Infect Dis; 2019; 32():101439. PubMed ID: 31238106
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hodgkin Lymphoma-related Vanishing Bile Duct Syndrome Cholestasis Resolved After Chemotherapy.
    Gonzalez R; Parmar P; Hardee S; Chang-Halpenny C; Titapiwatanakun R; Tcheng W; Au Yeung K; Fernández KS
    J Pediatr Hematol Oncol; 2022 Apr; 44(3):e728-e732. PubMed ID: 34133379
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Vanishing Bile Duct Syndrome Preceding the Diagnosis of Hodgkin Lymphoma.
    Anugwom C; Goetz G; Hassan M
    ACG Case Rep J; 2020 Feb; 7(2):e00336. PubMed ID: 32440528
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Vanishing bile duct syndrome after drug-induced liver injury.
    Wasuwanich P; Choudry H; So JM; Lowry S; Karnsakul W
    Clin Res Hepatol Gastroenterol; 2022 Nov; 46(9):102015. PubMed ID: 36067952
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ursodeoxycholic acid treatment of vanishing bile duct syndromes.
    Pusl T; Beuers U
    World J Gastroenterol; 2006 Jun; 12(22):3487-95. PubMed ID: 16773706
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Vanishing Bile Duct Syndrome Associated With Estrogen.
    Benfield J; Shah RA; Grider DJ; Sahebjam F
    ACG Case Rep J; 2022 May; 9(5):e00776. PubMed ID: 35919669
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Edoxaban-Induced Vanishing Bile Duct Syndrome: A Case Report With Review of the Literature.
    Borgonovo E; De Cristofaro J; Aletti F; Pedica F; D'Alessio A
    Cureus; 2024 Aug; 16(8):e68071. PubMed ID: 39347284
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Reversible vanishing bile duct syndrome induced by carbamazepine.
    Ramos AM; Gayotto LC; Clemente CM; Mello ES; Luz KG; Freitas ML
    Eur J Gastroenterol Hepatol; 2002 Sep; 14(9):1019-22. PubMed ID: 12352223
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hodgkin lymphoma associated vanishing bile duct syndrome treated successfully with a brentuximab based regimen.
    Morgan JD; Weishar RC; Kwok RM; Lieuw KM
    BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37989332
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Hodgkin’s lymphoma-related vanishing bile duct syndrome].
    Boldizsár S; Rottek J; Schneider T; Varga F; Szaleczky E
    Orv Hetil; 2021 May; 162(22):884-888. PubMed ID: 34052798
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Deeper Insights Into Vanishing Bile Duct Syndrome in Lymphoma: A Perplexing Entity.
    Sathyanarayanan V; Foo WC; Fanale M; Westin J
    Clin Lymphoma Myeloma Leuk; 2016 May; 16(5):e65-70. PubMed ID: 27050323
    [No Abstract]   [Full Text] [Related]  

  • 72. The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation.
    Ludwig J; Wiesner RH; Batts KP; Perkins JD; Krom RA
    Hepatology; 1987; 7(3):476-83. PubMed ID: 3552923
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Case report: Development of vanishing bile duct syndrome in Stevens-Johnson syndrome complicated by hemophagocytic lymphohistiocytosis.
    Lin WC; Hsieh TS; Chu CY
    Front Med (Lausanne); 2022; 9():975754. PubMed ID: 36353223
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Secondary Sclerosing Cholangitis and Hodgkin's Lymphoma.
    Abedi SH; Ghassami M; Molaei M; Mohsenifar Z; Mohammad Alizadeh AH
    Clin Med Insights Case Rep; 2015; 8():83-7. PubMed ID: 26380560
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A case of vanishing bile duct syndrome and IBD secondary to Hodgkin's lymphoma.
    DeBenedet AT; Berg CL; Enfield KB; Woodford RL; Bennett AK; Northup PG
    Nat Clin Pract Gastroenterol Hepatol; 2008 Jan; 5(1):49-53. PubMed ID: 18174907
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cholestasis secondary to Hodgkin's disease: report of 2 cases of vanishing bile duct syndrome.
    de Medeiros BC; Lacerda MA; Telles JE; da Silva JA; de Medeiros CR
    Haematologica; 1998 Nov; 83(11):1038-40. PubMed ID: 9864926
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cytomegalovirus infection does not increase the risk of vanishing bile duct syndrome after liver transplantation.
    van den Berg AP; Klompmaker IJ; Hepkema BG; Gouw AS; Haagsma EB; Lems SP; The TH; Slooff MJ
    Transpl Int; 1996; 9 Suppl 1():S171-3. PubMed ID: 8959818
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Vanishing bile duct syndrome associated with azithromycin in a 62-year-old man.
    Juricic D; Hrstic I; Radic D; Skegro M; Coric M; Vucelic B; Francetic I
    Basic Clin Pharmacol Toxicol; 2010 Jan; 106(1):62-5. PubMed ID: 19906050
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Improvement of vanishing bile duct syndrome with hyperlipidemia.
    Yamauchi R; Takata K; Fukunaga A; Tanaka T; Yokoyama K; Shakado S; Nabeshima K; Yoshimitsu K; Hirai F
    Clin J Gastroenterol; 2022 Aug; 15(4):784-790. PubMed ID: 35802301
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Primary non-Hodgkin lymphoma of the extra-hepatic bile duct: A case report.
    Pararas N; Foukas PG; Pikoulis A; Bagias G; Papakonstantinou D; Pappa V; Nastos K; Pikoulis E
    Mol Clin Oncol; 2022 Jul; 17(1):115. PubMed ID: 35747593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.